西亚试剂优势供应上万种化学试剂产品,欢迎各位新老客户咨询、选购!

登录

¥0.00

联系方式:400-990-3999 / 邮箱:sales@xiyashiji.com

西亚试剂 —— 品质可靠,值得信赖

西亚试剂:Senescence of Activated Stellate Cells Limits Liver Fibrosi

Senescence of Activated Stellate Cells Limits Liver Fibrosis

Valery Krizhanovsky,1 Monica Yon,1,3 Ross A. Dickins,1 Stephen Hearn,1 Janelle Simon,1,2 Cornelius Miething,1 Herman Yee,4 Lars Zender,1,5 and Scott W. Lowe1,2,

1 Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724 USA
2 Howard Hughes Medical Institute, Cold Spring Harbor, NY 11724 USA
3 Departamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de S?o Paulo and Instituto de Investiga??o em Imunologia, Instituto do Milênio, Brazil
4 Department of Pathology, New York University School of Medicine, New York, NY 10016, USA

Cellular senescence acts as a potent mechanism of tumor suppression; however, its functional contribution to noncancer pathologies has not been examined. Here we show that senescent cells accumulate in murine livers treated to produce fibrosis, a precursor pathology to cirrhosis. The senescent cells are derived primarily from activated hepatic stellate cells, which initially proliferate in response to liver damage and produce the extracellular matrix deposited in the fibrotic scar. In mice lacking key senescence regulators, stellate cells continue to proliferate, leading to excessive liver fibrosis. Furthermore, senescent activated stellate cells exhibit gene expression profile consistent with cell-cycle exit, reduced secretion of extracellular matrix components, enhanced secretion of extracellular matrix-degrading enzymes, and enhanced immune surveillance. Accordingly natural killer cells preferentially kill senescent activated stellate cells in vitro and in vivo, thereby facilitating the resolution of fibrosis. Therefore, the senescence program limits the fibrogenic response to acute tissue damage.